|

TGRX-814 Clinical Trials

1 actively recruiting trial

Also known as: TGRX-814 monotherapy

Pipeline

Phase 1/2: 1

Top Sponsors

  • Shenzhen TargetRx Co., Ltd.1

Indications

  • Acute Lymphoblastic Leukemia, Adult1
  • Non-hodgkin Lymphoma1
  • Acute Myeloid Leukemia1
  • Hematologic Malignancy1
  • Myelodysplastic Syndromes1

Other1 trial

TGRX-814 Chinese Phase I/II in Patients With Hematological Malignancies
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.